Inovio’s SynCon dengue virus DNA vaccine showed neutralized antibody responses against all four distinct serotypes of dengue viruses, that are transmitted to humans by mosquitoes. The company’s scientists
PTC has initiated a phase 2 clinical trial of PTC299 in adult patients with neurofibromatosis type 2 (NF2), a rare genetic disorder that causes the development of non-malignant
Sanofi-aventis and Merieux Alliance have signed a strategic agreement for the acquisition of Merieux Alliance’s French subsidiary, ShanH, by Sanofi Pasteur. ShanH owns a majority stake in vaccine
Taro Pharmaceutical Industries has filed a lawsuit against Synerx Pharma, DPT Laboratories, and Karalex Pharma in the United States District Court for New Jersey. The case is for
PacificGMP and the University of Southern California (USC) have signed an agreement whereby PacificGMP will provide development and manufacturing services for USC. Under the terms of the agreement,
Taro Pharmaceutical Industries (Taro) has received approval from FDA for its Abbreviated New Drug Application (ANDA) for cetirizine hydrochloride tablets (OTC), 5mg and 10mg (Cetirizine Tablets). The product
Tranzyme has received FDA Fast Track status for the company’s oral gastrointestinal (GI) prokinetic drug candidate TZP-102. It is intended for the treatment of gastroparesis in diabetic patients.
FDA has accepted CyDex’s Investigational New Drug (IND) application for a clinical study of Captisol-enabled melphalan HCL (CDX-353). Melphalan is an FDA-approved low dose chemotherapy for multiple myeloma
RXi Pharmaceuticals has exercised its option to an exclusive worldwide license to novel technologies from Advirna, to enable in-vivo delivery of RNAi therapeutics. Terms of the agreement were
Terms of the agreement stipulate that neither party will sue each other in the field of coronary stent and stent delivery systems for a period of at least
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.